Japan vs United Arab Emirates: Share of S. aureus infections resistant to methicillin
Japan
33.9%
in 2022
United Arab Emirates
39.9%
in 2022
Japan rank
18th
United Arab Emirates rank
15th
Share of S. aureus infections resistant to methicillin over time
- Japan
- United Arab Emirates
How they compare
United Arab Emirates currently reports 39.9% against 33.9% in Japan, a difference of 6.0%.
That makes United Arab Emirates's figure about 1.2 times Japan's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Japan ahead.
Japan ranks 18th and United Arab Emirates ranks 15th of 45 countries.
Across the 2 decades both report, Japan averaged higher in 1 and United Arab Emirates in 1.
Head to head by decade
| Decade | Japan | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 39.6% | 31.3% | 8.2% | Japan |
| 2020s | 34.9% | 39.4% | 4.4% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Japan or United Arab Emirates?
- United Arab Emirates, at 39.9% against 33.9% in Japan as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Japan and United Arab Emirates?
- 6.0%, with United Arab Emirates ahead.
- How many years of comparable data are there for Japan and United Arab Emirates?
- 6 years are reported by both, from 2017 to 2022.
- How do Japan and United Arab Emirates rank globally for share of s. aureus infections resistant to methicillin?
- Japan ranks 18th and United Arab Emirates ranks 15th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).